Clinical Trials

Participating in a clinical trial may enable patients to access the newest lung cancer treatments before they are widely available. Patients in clinical trials also receive high-quality care, while helping researchers improve care for many current and future cancer patients.

Learn more about clinical trials below.

How Clinical Trials Work

Cancer clinical trials can have more than one group of patients to help doctors evaluate the efficacy of different treatments. However, all patients in cancer clinical trials receive treatment — regardless of whether they are in the control or placebo group.

Even if they are in a “placebo” group, patients rarely receive placebos (sugar pills) in clinical trials. Instead, those in the control group receive the standard of care (i.e., cancer therapies that are currently approved for their type of cancer) and are closely watched by the doctors and nurses running the trial.

Because clinical trials are testing new therapies, there are risks to participating. Any patient considering participating in a clinical trial should seek out as much information as possible in order to fully understand the treatments being tested and how they may affect him or her.

How to Find the Right One

If you are interested in participating in a clinical trial, speak with your doctor about whether it could be right for you.

The Lung Cancer Research Foundation has partnered with Antidote to offer people with lung cancer a way to take action and be aware of all your treatment options. This free, confidential, personalized service helps you understand which lung cancer clinical trials may be an option for you.

You can also find more information through these resources: